Chris Greene

@chrisgreene.bsky.social

Lecturer in Physiology at RCSI. Researcher at FutureNeuro. Neuroscience, blood-brain barrier, long Covid, TBI... beer, coffee. #NewPI

Delighted to share our latest review in Nature Reviews Neuroscience! We examine the growing evidence that vascular dysfunction plays a key role in cognitive decline in ageing and dementia, and argue that preserving/restoring CBF should be central to future therapies. www.nature.com/articles/s41...

The vascular contribution to cognitive decline in ageing and dementia - Nature Reviews Neuroscience

Growing evidence suggests that reduced cerebral blood flow contributes to cognitive decline in ageing and dementia. Attwell and colleagues discuss the underlying mechanisms and functional consequences...

nature.com

A new collaborative study led by FutureNeuro researchers at RCSI offers hope for predicting and preventing the development of epilepsy following traumatic brain injury. The research identifies an important role for a brain receptor called P2X7. More ➡️ www.rcsi.com/dublin/news-... #RCSIdiscover

New research offers hope for preventing epilepsy after traumatic brain injury

A new international study has unveiled critical insights in understanding post-traumatic epilepsy, a condition that can develop following traumatic brain injury.

rcsi.com

The blood-brain barrier can prevent therapeutic drugs from reaching the brain. Researchers in #ScienceAdvances have identified a peptide that increases the barrier’s permeability, showing potential for more effective drug delivery to treat brain diseases. scim.ag/4jhnWf6

A claudin5-binding peptide enhances the permeability of the blood-brain barrier in vitro

A claudin5 binding peptide enhances transport across the blood-brain barrier by transiently permeabilizing tight junctions.

scim.ag